Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F9DDG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,733
Award facts
- Contract value 100% obligated
- $13,732.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,732.80 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pens on January 13, 2026, with an ultimate completion date of January 14, 2026. This competitive award, issued without set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Repatha is a prescription medication used to treat high cholesterol, and this delivery order represents a single task order fulfilling specific pharmaceutical supply requirements within the DLA's medical procurement operations.
This delivery order is executed under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This comprehensive IDC serves as the primary vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare systems globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The firm fixed-price delivery order structure reflects DLA's efficient utilization of its established pharmaceutical prime vendor relationship to procure specific medical products as needed.
Quick answers
Who was awarded contract SPE2DR26F9DDG?
SPE2DR26F9DDG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F9DDG worth?
The government has obligated $13,733 on SPE2DR26F9DDG.
Is contract SPE2DR26F9DDG an order under another contract?
Yes. SPE2DR26F9DDG is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9DDG competed?
The extent of competition for SPE2DR26F9DDG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award